Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ANGIODYNAMICS INC Director's Dealing 2017

Jul 28, 2017

32939_dirs_2017-07-28_318e4e35-b26b-493c-9639-2eb0512768a4.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ANGIODYNAMICS INC (ANGO)
CIK: 0001275187
Period of Report: 2017-07-26

Reporting Person: Campbell Chad Thomas (SVP/GM, Vascular Access)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-07-26 Common Stock A 3342 Acquired 15606 Direct
2017-07-27 Common Stock F 282 $16.36 Disposed 15324 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2017-07-26 Non-Qualified Stock Option (right to buy) $16.55 A 11744 Acquired 2027-07-26 Common Stock (11744) Direct
2017-07-26 Performance Right $ A 6684 Acquired Common Stock (6684) Direct

Footnotes

F1: This acquisition of 3,342 shares of common stock ("Common Stock") of AngioDynamics, Inc. represents 3,342 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. These restricted stock units vest in four equal annual installments beginning on July 26, 2018, such that 25% of the restricted stock units will vest on each of July 26, 2018, 2019, 2020 and 2021.

F2: The exempt disposition of 282 shares of Common Stock was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 27, 2016.

F3: These stock options vest in four equal annual installments beginning on July 26, 2018, such that 25% of the options will vest on each of July 26, 2018, 2019, 2020 and 2021.

F4: Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period ending May 31, 2020. Any shares that do not vest at the end of the performance period will be forfeited.